New patent for Biocryst drug RAPIVAB

Annual Drug Patent Expirations for RAPIVAB Rapivab is a drug marketed by Biocryst and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent for Biocryst drug RAPIVAB appeared first on DrugPat…


New patent for Biocryst drug RAPIVAB

Annual Drug Patent Expirations for RAPIVAB Rapivab is a drug marketed by Biocryst and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent for Biocryst drug RAPIVAB appeared first on DrugPat…


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog